NuView Life Sciences Secures $90M for NV-VPAC1 Cancer Portfolio
NuView Life Sciences will use the funds to complete a 600-patient in vitro double-blind clinical trial for the NV-VPAC1 cancer portfolio.
Read More
Search Results for: prostate cancer
Liquid Biopsy Research Reveals New Insights on Genetic Changes in Cancer
Researchers used Menarini Silicon Biosystems’ liquid biopsy technology to learn more about genetic changes in circulating cancer cells.
Read More
NIH Scientists Develop Blood Test to Help Improve Liver Cancer Screening
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read MoreBiocare Medical Launches Seven Antibody Markers for Clinical Diagnostic and Cancer Research Applications
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
Read More
Cancer Detection and Liquid Biopsy
Analysis of cell-free DNA in blood samples is revolutionizing cancer treatment and prognosis.
Read More